Alignment Healthcare price target raised to $21 from $14 at Piper Sandler

Piper Sandler raised the firm’s price target on Alignment Healthcare (ALHC) to $21 from $14 and keeps an Overweight rating on the shares. The Alignment flywheel is gaining momentum across states, the firm says. It consists of repeatable, scalable processes and protocols that advance the four foundational goals of MA, namely expand beneficiary choice/ access, improve experience, optimize clinical outcomes, and control costs, Piper adds. The flywheel’s repeatable, scalable processes and protocols establish local care delivery infrastructure and coordination, engage patients, close gaps, reduce inpatient admissions, boost quality and garner best-in-class Star Ratings for Alignment’s contracts, in the firm’s view.